AIM: To evaluate the effectiveness of simethicone in enhancing visibility and efficacy during colonoscopy. METHODS: A prospective, double-blind, randomized, placebo-controlled study was conducted. One hundred and twenty-four patients were allocated to receive 2 doses of sodium phosphate plus 240 mg of tablet simethicone or placebo as bowel preparation. Visibility was blindly assessed for the amount of air bubbles and adequacy of colon preparation. Total colonoscopic time, side effects of the medication, endoscopist and patient satisfaction were also compared. RESULTS:Sodium phosphate plus simethicone, compared to sodium phosphate plus placebo, improved visibility by diminishing air bubbles (100.00% vs 42.37%, P < 0.0001) but simethicone failed to demonstrate improvement in adequacy of colon preparation (90.16% vs 81.36%, P = 0.17). Endoscopist and patient satisfaction were increased significantly in the simethicone group. However, there was no difference in the total duration of colonoscopy and side effects of the medication. CONCLUSION: The addition of simethicone is of benefit for colonoscopic bowel preparation by diminishing air bubbles, which results in enhanced visibility. Endoscopist and patient satisfaction is also increased.
RCT Entities:
AIM: To evaluate the effectiveness of simethicone in enhancing visibility and efficacy during colonoscopy. METHODS: A prospective, double-blind, randomized, placebo-controlled study was conducted. One hundred and twenty-four patients were allocated to receive 2 doses of sodium phosphate plus 240 mg of tablet simethicone or placebo as bowel preparation. Visibility was blindly assessed for the amount of air bubbles and adequacy of colon preparation. Total colonoscopic time, side effects of the medication, endoscopist and patient satisfaction were also compared. RESULTS:Sodium phosphate plus simethicone, compared to sodium phosphate plus placebo, improved visibility by diminishing air bubbles (100.00% vs 42.37%, P < 0.0001) but simethicone failed to demonstrate improvement in adequacy of colon preparation (90.16% vs 81.36%, P = 0.17). Endoscopist and patient satisfaction were increased significantly in the simethicone group. However, there was no difference in the total duration of colonoscopy and side effects of the medication. CONCLUSION: The addition of simethicone is of benefit for colonoscopic bowel preparation by diminishing air bubbles, which results in enhanced visibility. Endoscopist and patient satisfaction is also increased.
Authors: Fernando de la Portilla; Ignacio Ynfante; Ana Fernández; Daniel Bejarano; Gonzalo Carranza Journal: Dis Colon Rectum Date: 2003-10 Impact factor: 4.585
Authors: John F Johanson; John W Popp; Lawrence B Cohen; Sandra R Lottes; William P Forbes; Kelli Walker; Edwin Carter; Bing Zhang; Martin Rose Journal: Am J Gastroenterol Date: 2007-06-15 Impact factor: 10.864
Authors: Dushyant V Sahani; Kartik S Jhaveri; Roy V D'souza; Jose C Varghese; Elkan Halpern; Mukesh G Harisinghani; Peter F Hahn; Sanjay Saini Journal: Acad Radiol Date: 2003-05 Impact factor: 3.173
Authors: Christian Ell; Wolfgang Fischbach; Hans-Joachim Bronisch; Stefan Dertinger; Peter Layer; Michael Rünzi; Thomas Schneider; Günther Kachel; Jörg Grüger; Michael Köllinger; Waltraud Nagell; Karl-Josel Goerg; Roland Wanitschke; Hans-Jürgen Gruss Journal: Am J Gastroenterol Date: 2008-01-11 Impact factor: 10.864
Authors: P Ducrotte; J C Grimaud; M Dapoigny; S Personnic; V O'Mahony; M C Andro-Delestrain Journal: Int J Clin Pract Date: 2013-10-21 Impact factor: 2.503